| Overall N = 85 | ACPR N = 65 | ETF N = 1 | Recrudescence N = 4 | Reinfection N = 14 |
---|---|---|---|---|---|
pfk13a | n = 83 | n = 65 | n = 1 | n = 3 | n = 14 |
 Wild type (no mutations detected) | 83 (100%) | 65 (100%) | 1 (100%) | 3 (100%) | 14 (100%) |
pfmdr1 N86Y | |||||
 Successfully amplified | n = 81 | n = 62 | n = 1 | n = 4 | n = 14 |
 N | 64 (79%) | 48 (78%) | 1 (100%) | 3 (75%) | 12 (86%) |
 N/Y | 2 (3%) | 2 (3%) | 0 (0%) | 0 (0%) | 0 (0%) |
 Y | 15 (19%) | 12 (19%) | 0 (0%) | 1 (25%) | 2 (14%) |
Y184F | |||||
 Successfully amplified | n = 82 | n = 63 | n = 1 | n = 4 | n = 14 |
 Y | 34 (41%) | 23 (36%) | 1 (100%) | 1 (25%) | 9 (64%) |
 Y/F | 7 (9) | 6 (10%) | 0 (0%) | 0 (0%) | 1 (7%) |
 F | 41 (50%) | 34 (54%) | 0 (0%) | 3 (75%) | 4 (29%) |
S1034C | |||||
 Successfully amplified | n = 77 | n = 59 | n = 1 | n = 4 | n = 13 |
 S | 77 (100%) | 59 (100%) | 1 (100%) | 4 (100%) | 13 (100%) |
N1042D | |||||
 Successfully amplified | n = 77 | n = 59 | n = 1 | n = 4 | n = 13 |
 N | 77 (100%) | 59 (100%) | 1 (100%) | 4 (100%) | 13 (100%) |
D1246Y | |||||
 Successfully amplified | n = 77 | n = 59 | n = 1 | n = 4 | n = 13 |
 D | 73 (95%) | 57 (97%) | 1 (100%) | 3 (75%) | 12 (92%) |
 D/Y | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
 Y | 4 (5%) | 2 (3%) | 0 (0%) | 1 (25%) | 1 (8%) |
pfmdr1 haplotypesb | |||||
 Amplified for all 3 codons (86, 184, 1246) | n = 74 | n = 56 | n = 1 | n = 4 | n = 13 |
 NFD | 37 (50%) | 28 (50%) | 1 (100%) | 3 (75%) | 5 (27%) |
 NYD | 30 (41%) | 23 (41%) | 0 (0%) | 0 (0%) | 7 (38%) |
 YFD | 6 (8%) | 5 (9%) | 0 (0%) | 1 (25%) | 0 (0%) |
 YYD | 8 (11%) | 6 (11%) | 0 (0%) | 0 (0%) | 2 (11%) |
 YYY | 1 (1%) | 0 (0%) | 0 (0%) | 0 (0%) | 1 (5%) |
 YFY | 1 (1%) | 1 (1%) | 0 (0%) | 0 (0%) | 0 (0%) |
 NFY | 2 (3%) | 1 (1%) | 0 (0%) | 0 (0%) | 1 (5%) |
pfcrt haplotypes | |||||
 Amplified for all 5 codons (72—76) | n = 82 | n = 63 | n = 1 | n = 4 | n = 14 |
 CVMNK | 82 (100%) | 63 (100%) | 1 (100%) | 4 (100%) | 14 (100%) |